Hansa Biopharma AB
Biotechnology · Healthcare
COO
1 appearance
Latest appearance 2026-07-22
COO
Hansa Biopharma AB
Equibles does not estimate personal net worth.
Maria Tarnson is recorded as COO at Hansa Biopharma AB. Maria Tarnson has spoken on 1 earnings call across 1 company, most recently for Hansa Biopharma AB on July 22, 2026. Hansa Biopharma AB is classified in the Biotechnology industry within the Healthcare sector.
“Our 2026 Q2 results were in line with results in Q2 2025, with a slight decrease of 1 million sec. However, a significantly better performance, an increase of 39% compared to Q1 2026.”
Hansa Biopharma AB
COO
Transcript header (unverified)
Hansa Biopharma AB
Biotechnology · Healthcare
COO
Interim Report January-June 2026 Conference Call
Hansa Biopharma AB